Statistical issues and challenges.

作者: Meredith M. Regan

DOI: 10.1007/978-0-387-75115-3_6

关键词:

摘要:

参考文章(40)
Maureen Cronin, Mylan Pho, Debjani Dutta, James C. Stephans, Steven Shak, Michael C. Kiefer, Jose M. Esteban, Joffre B. Baker, Measurement of gene expression in archival paraffin-embedded tissues: development and performance of a 92-gene reverse transcriptase-polymerase chain reaction assay. American Journal of Pathology. ,vol. 164, pp. 35- 42 ,(2004) , 10.1016/S0002-9440(10)63093-3
Richard M Simon, Edward L Korn, Lisa M McShane, Michael D Radmacher, George W Wright, Yingdong Zhao, Design and Analysis of DNA Microarray Investigations ,(2003)
Mary Kathryn Cowles, Modelling Survival Data in Medical Research (2nd ed.) (Book) Journal of the American Statistical Association. ,vol. 99, pp. 905- 906 ,(2004)
Jacqueline Benedetti, John Crowley, Stephanie Green, Clinical Trials in Oncology ,(1997)
Laurel A Habel, Steven Shak, Marlena K Jacobs, Angela Capra, Claire Alexander, Mylan Pho, Joffre Baker, Michael Walker, Drew Watson, James Hackett, Noelle T Blick, Deborah Greenberg, Louis Fehrenbacher, Bryan Langholz, Charles P Quesenberry, A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients Breast Cancer Research. ,vol. 8, pp. 1- 15 ,(2006) , 10.1186/BCR1412
Peter M. Ravdin, Laura A. Siminoff, Greg J. Davis, Mary Beth Mercer, Joan Hewlett, Nancy Gerson, Helen L. Parker, Computer Program to Assist in Making Decisions About Adjuvant Therapy for Women With Early Breast Cancer Journal of Clinical Oncology. ,vol. 19, pp. 980- 991 ,(2001) , 10.1200/JCO.2001.19.4.980
D Slamon, W Eiermann, N Robert, T Pienkowski, M Martin, J Rolski, A Chan, J Mackey, M Liu, T Pinter, V Valero, C Falkson, T Fornander, T Shiftan, S Olsen, M Buyse, T Kiskartalyi, V Landreau, V Wilson, M Press, J Crown, BCIRG006 Investigators, Phase III Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Docetaxel (AC→T) with Doxorubicin and Cyclophosphamide Followed by Docetaxel and Trastuzumab (AC→TH) with Docetaxel, Carboplatin and Trastuzumab (TCH) in Her2neu Positive Early Breast Cancer Patients: BCIRG 006 Study. Cancer Research. ,vol. 69, pp. 62- 62 ,(2009) , 10.1158/0008-5472.SABCS-09-62
Joseph A. Sparano, TAILORx: trial assigning individualized options for treatment (Rx). Clinical Breast Cancer. ,vol. 7, pp. 347- 350 ,(2006) , 10.3816/CBC.2006.N.051
Jan Bogaerts, Fatima Cardoso, Marc Buyse, Sofia Braga, Sherene Loi, Jillian A Harrison, Jacques Bines, Stella Mook, Nuria Decker, Peter Ravdin, Patrick Therasse, Emiel Rutgers, Laura J Van't Veer, Martine Piccart, None, Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trial. Nature Reviews Clinical Oncology. ,vol. 3, pp. 540- 551 ,(2006) , 10.1038/NCPONC0591